London and Philadelphia-based Ori Biotech Ltd, a provider of cell and gene therapy manufacturing, has raised $9.4 million in seed funding. The investors included Amadeus Capital Partners, Delin Ventures and Kindred Capital.
Source: Press Release
Ori Biotech nets $9.4 mln seed
London and Philadelphia-based Ori Biotech Ltd, a provider of cell and gene therapy manufacturing, has raised $9.4 million in seed funding.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: